SCHEMBL6698490

SCHEMBL6698490

CC(C)n1nc(-c2ccc(O)c(O)c2)c2cccc(F)c21

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.53
PIK3CD O00329 13/20 0.44
ABL1 P00519 13/20 0.44
EGFR P00533 13/20 0.44
HCK P08631 13/20 0.44
SRC P12931 13/20 0.44
KDR P35968 13/20 0.44
PIK3CA P42336 13/20 0.44
PIK3CB P42338 13/20 0.44
MTOR P42345 13/20 0.44
PIK3CG P48736 13/20 0.44
EPHB4 P54760 13/20 0.44
PRKDC P78527 13/20 0.44
PI4KB Q9UBF8 12/20 0.44
BACE1 P56817 1/20 0.37
KMT2A Q03164 1/20 0.36
APP P05067 1/20 0.36
ALOX5 P09917 1/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4030477 0.85 ESR1 (0.70) ESR1PIK3CDABL1EGFRHCK
SCHEMBL4029561 0.83 ESR1 (0.44) ESR1APPALOX5IDO1
SCHEMBL4027041 0.80 ESR1 (0.60) ESR1PIK3CDABL1EGFRHCK
SCHEMBL4026032 0.80 ESR1 (0.60) ESR1PIK3CDABL1EGFRHCK
SCHEMBL5397335 0.78 ESR1 (0.51) ESR1PIK3CDABL1EGFRHCK
SCHEMBL5397380 0.78 ESR1 (0.56) ESR1KMT2AAPPALOX5
SCHEMBL4035727 0.76 ESR1 (0.57) ESR1KMT2A
SCHEMBL4026000 0.75 ESR1 (0.73) ESR1PIK3CDABL1EGFRHCK
SCHEMBL4035132 0.75 ESR1 (0.56) ESR1
SCHEMBL4028977 0.73 ESR1 (0.64) ESR1PIK3CDABL1EGFRHCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040167127-A1 Substituted 4-(indazol-3-yl)phenols WYETH (US) 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167127-A1 Substituted 4-(indazol-3-yl)phenols INSR, MSR1, TNNI3 ESR1 2487/4885PIK3CD 2207/4885ABL1 1747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.